Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $1,488 - $1,775
-33 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $298 Million - $386 Million
-6,102,392 Reduced 100.0%
33 $2,000
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $337 Million - $380 Million
6,102,425 New
6,102,425 $379 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.